About
Nexeon Medsystems, Inc. (OTCQB: NXNN) is a global medical device company focused on providing innovative neurostimulation products that improve the quality of life of patients suffering from debilitating neurological diseases. Nexeon has developed and commercialized the Synapse™ neurostimulation system, an adaptive, closed-loop platform that can be utilized to treat a variety of neurological diseases. Our lead program utilizes the Synapse™ system for deep brain stimulation for the treatment of the symptoms associated with Parkinson's disease.
Technologies
Cloudflare DNS
CloudFlare Hosting
Mobile Friendly
Facebook Login (Connect)
Linkedin Widget
Hubspot
Google Plus
Facebook Widget
Linkedin Login
Phoenix
Keywords
bioelectronics
rd
rampd
medtech
interventional cardiology
medical devices
medical equipment manufacturing
medical device r&d
active implantable devices
neurostimulation systems
bioelectronics patents
clinical data within 18 months
iot technology
capital-efficient clinical science
software platforms
neuromodulation
capital-efficient development
investor relations
implantable devices
medical device development
neurostimulation for parkinson's
iot in healthcare
clinical research
investigational medical device
deep brain stimulation
bioelectronics innovation
closed-loop neurostimulation
neurostimulation
medical device manufacturing
medical equipment and supplies manufacturing
Company Information
-
Employees 62
-
Founded 2004
-
Annual Revenue $3302000
-
Total Funding $5578510
Location
1910 Pacific Ave, Dallas, Texas, United States, 75201
